Replies to post #801973 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

So, Advent is Schrodinger's CDMO? It is (according to some here) worthless with only 1 non-paying customer while it should also command a min of 300 Million.

Exactly. The attitude expressed about the Advent purchase is a litmus test to distinguish between disgruntled NWBO shareholders and folks who are just always arguing the negative in bad faith.

The real shareholders like myself who are pro-DCVax but who have little use for NWBO management are still willing to say ‘The Advent sale is a good sign.’ We were justifiably concerned about a repeat wherein, like Cognate NWBO management (perfectly legally)pumped our money into Advent and (perfectly legally) and then Advent would be sold and shareholders would have little tangible to show for it.

We were willing to take Yes for an answer when, after years, NWBO did properly address the Advent issue not with words but actions and exorcised the ghost of Cognate that had been haunting shareholder relations.

By contrast, those always arguing the negative in bad faith (because they are trolls etc) will reveal themselves by not taking an actual Yes for an answer and flipping their argument to whatever is bad for NWBO. So when NWBO doesn’t own Advent it’s worth a lot and then suddenly when we do own Advent now somehow Advent is worthless.

[learningcurve2020]

You need to remember for years just a few of us here were complaining about LP and her private CDMO arrangement. Hopefully applying pressure. I was excited when they announced it was folding up into NWBO, and I constantly used PPHM here as an example of what can be for retail. But now Advent is public and as such should have a clear forward looking multiples market cap, so where is it? LP did nothing to help the case. She could’ve had an analyst all lined up. For all we know she passed off a shell to shareholders. 🤷‍♀️

[barnstormer]

Nice reference, and the paradox does fit in a limited way.